Cryoport, Inc. (CYRX) Key Metrics
CYRX valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $852.9M
- Enterprise value
- $768.0M
- P/E (TTM)
- —
- Forward P/E
- 79.4
- PEG ratio
- 62.13
- Price / sales
- 4.6 10-yr median 9.1
- Price / book
- 2.0 10-yr median 4.3
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 1.96
CYRX key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsCYRX valuation Price multiples at each fiscal year-end price.
CYRX returns How much profit the business earns on the capital it uses.
CYRX per-share figures Results divided by the shares outstanding at year-end.
CYRX financial health Debt, liquidity and how easily interest is covered.
CYRX efficiency & capital use Working capital cycle and where the cash goes.
CYRX valuation history
CYRX returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CYRX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CYRX cash returned to shareholders
CYRX price vs earnings per share
CYRX key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $480.7M | $379.2M | $758.8M | $796.8M | $2.72B | $1.69B | $549.7M | $311.2M | $197.3M | $46.1M |
| Enterprise value | $300.2M | $368.1M | $718.1M | $709.4M | $2.52B | $1.73B | $460.2M | $278.7M | $182.2M | $42.2M |
| P/E ratio | 6.1 | — | — | — | — | — | — | — | — | — |
| Price / sales | 2.7 | 1.6 | 3.2 | 3.6 | 12.2 | 21.5 | 16.2 | 15.9 | 16.5 | 6.0 |
| Price / book | 1.0 | 0.9 | 1.6 | 1.4 | 4.2 | 4.4 | 4.4 | 8.1 | 11.0 | 8.1 |
| Price / operating cash flow | — | — | — | — | 334.4 | — | — | — | — | — |
| EV / sales | 1.7 | 1.6 | 3.0 | 3.2 | 11.3 | 22.0 | 13.6 | 14.2 | 15.2 | 5.5 |
| Earnings yield | 16.3% | −26.3% | −4.9% | −34.6% | −10.1% | −1.9% | −3.3% | −3.1% | −4.0% | −28.5% |
| Free cash flow yield | −5.8% | −8.9% | −6.0% | −3.3% | −0.6% | −1.4% | −1.2% | −2.0% | −2.7% | −14.7% |
| Dividend yield | 1.7% | 2.1% | 1.1% | 1.0% | 0.3% | 0.2% | — | — | — | 2,318.0% |
| Shareholder yield (dividends + buybacks) | 3.7% | 2.1% | 1.1% | 5.8% | 0.3% | 0.2% | 0.0% | 0.0% | 0.0% | 12,986.5% |
| Share price at fiscal year-end | $9.60 | $7.78 | $15.49 | $17.35 | $59.17 | $43.88 | $16.46 | $11.03 | $8.59 | $3.24 |
| Per share | ||||||||||
| Revenue per share | $3.52 | $4.79 | $4.84 | $4.85 | $4.85 | $2.04 | $1.02 | $0.70 | $0.52 | $0.54 |
| Earnings per share | $1.56 | −$2.04 | −$0.76 | −$6.00 | −$6.00 | −$0.85 | −$0.55 | −$0.34 | −$0.34 | −$0.92 |
| Operating cash flow per share | −$0.17 | −$0.33 | −$0.02 | −$0.04 | $0.18 | −$0.39 | −$0.04 | −$0.12 | −$0.16 | −$0.40 |
| Free cash flow per share | −$0.56 | −$0.69 | −$0.93 | −$0.57 | −$0.37 | −$0.64 | −$0.20 | −$0.22 | −$0.23 | −$0.48 |
| Cash per share | $8.21 | $5.37 | $9.32 | $11.39 | $13.69 | $2.42 | $2.82 | $1.68 | $0.66 | $0.32 |
| Book value per share | $10.04 | $8.25 | $9.98 | $12.10 | $13.97 | $9.92 | $3.78 | $1.37 | $0.78 | $0.40 |
| Tangible book value per share | $6.83 | $3.69 | $3.80 | $4.65 | $6.39 | $0.61 | $3.30 | $1.36 | $0.77 | $0.40 |
| Dividends per share | $0.16 | $0.16 | $0.16 | $0.17 | $0.18 | $0.07 | — | — | — | $75.10 |
| Capex per share | $0.39 | $0.35 | $0.92 | $0.53 | $0.54 | $0.25 | $0.16 | $0.10 | $0.08 | $0.08 |
| Debt per share | $4.61 | $5.14 | $8.49 | $9.49 | $9.30 | $3.39 | $0.14 | $0.52 | $0.00 | $0.05 |
| Shares outstanding | 50.1M | 48.7M | 49.0M | 45.9M | 45.9M | 38.6M | 33.4M | 28.2M | 23.0M | 14.2M |
| Change in shares outstanding | +2.7% | −0.5% | +6.7% | 0.0% | +19.0% | +15.5% | +18.4% | +22.9% | +61.5% | — |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 17.3% | −22.4% | −7.1% | −46.0% | −53.8% | −12.8% | −22.2% | −33.9% | −67.0% | −245.8% |
| Return on invested capital (ROIC) | −8.2% | −21.7% | −5.5% | −3.1% | −3.3% | −10.4% | −65.2% | −153.4% | −268.0% | −546.9% |
| Return on assets (ROA) | 10.7% | −12.0% | −3.7% | −25.6% | −33.1% | −9.5% | −19.0% | −24.9% | −55.7% | −168.4% |
| Return on tangible assets | 13.0% | −20.7% | −5.7% | −39.6% | −36.0% | −16.9% | −15.3% | −16.9% | −39.2% | −161.8% |
| Free cash flow margin | −15.9% | −14.4% | −19.2% | −11.7% | −7.6% | −31.2% | −19.8% | −32.2% | −45.0% | −88.4% |
| Income quality (OCF / net income) | −0.11 | — | — | — | — | — | — | — | — | — |
| Financial health | ||||||||||
| Total debt | $230.7M | $250.7M | $416.0M | $435.9M | $427.1M | $130.9M | $4.8M | $14.8M | $0 | $651,934 |
| Cash & short-term investments | $411.2M | $261.7M | $456.8M | $523.3M | $628.8M | $93.3M | $94.3M | $47.3M | $15.0M | $4.5M |
| Net debt | −$180.5M | −$11.0M | −$40.8M | −$87.4M | −$201.7M | $37.6M | −$89.5M | −$32.5M | −$15.0M | −$3.9M |
| Debt / equity | 0.46 | 0.62 | 0.85 | 0.78 | 0.67 | 0.34 | 0.04 | 0.38 | 0.00 | 0.11 |
| Debt / assets | 0.30 | 0.36 | 0.43 | 0.42 | 0.38 | 0.24 | 0.04 | 0.26 | 0.00 | 0.08 |
| Current ratio | 2.17 | 5.29 | 11.73 | 14.79 | 16.26 | 4.20 | 18.85 | 16.91 | 7.92 | 2.73 |
| Quick ratio | 2.07 | 4.94 | 11.16 | 14.11 | 15.88 | 3.90 | 18.77 | 16.84 | 7.86 | 2.69 |
| Interest coverage | -15.6 | -20.9 | -5.2 | -3.8 | -3.8 | -11.7 | -12.9 | -124.8 | -502.9 | -62.9 |
| Working capital | $257.2M | $277.0M | $489.5M | $563.3M | $650.9M | $112.1M | $97.5M | $48.7M | $15.1M | $3.9M |
| Invested capital | $322.1M | $390.9M | $448.3M | $468.4M | $440.1M | $420.3M | $36.8M | $6.1M | $2.8M | $1.8M |
| Tangible asset value | $342.2M | $179.8M | $186.2M | $213.7M | $293.4M | $23.5M | $110.1M | $38.4M | $17.8M | $5.7M |
| Net current asset value | $213.8M | $40.0M | $66.4M | $121.3M | $222.4M | −$22.6M | $93.4M | $33.7M | $14.9M | $3.7M |
| Graham number | $18.79 | — | — | — | — | — | — | — | — | — |
| Graham net-net per share | $3.70 | $0.12 | $0.67 | $1.90 | $4.26 | −$1.23 | $2.70 | $1.13 | $0.61 | $0.21 |
| Capital allocation | ||||||||||
| Dividends paid | $8.0M | $8.0M | $8.0M | $8.0M | $8.2M | $2.8M | — | — | — | $1.07B |
| Share buybacks (net) | $10.0M | $0 | $0 | $38.0M | $0 | $0 | $0 | $0 | $0 | $4.92B |
| Dividend payout ratio | 10.2% | — | — | — | — | — | — | — | — | — |
| Capex / revenue | 11.1% | 7.4% | 18.9% | 10.9% | 11.2% | 12.3% | 15.9% | 15.1% | 15.1% | 13.9% |
| Capex / operating cash flow | — | — | — | — | 307.7% | — | — | — | — | — |
| Capex / depreciation | 0.70 | 0.56 | 1.63 | 1.06 | 1.24 | 0.98 | 2.24 | 3.45 | 2.71 | 2.85 |
| Stock-based compensation / revenue | 6.3% | 8.4% | 9.6% | 9.0% | 6.9% | 11.3% | 48.7% | 27.9% | 29.7% | 40.6% |
| R&D / revenue | 9.7% | 7.7% | 6.6% | 7.6% | 7.6% | 12.1% | 11.0% | 9.4% | 10.1% | 7.8% |
| SG&A / revenue | 58.4% | 63.9% | 59.3% | 53.9% | 43.8% | 72.3% | 92.2% | 86.8% | 105.8% | 146.8% |
| Efficiency | ||||||||||
| Days sales outstanding | 82.0 | 68.7 | 66.1 | 68.3 | 58.0 | 89.2 | 57.2 | 48.1 | 43.1 | 43.1 |
| Days of inventory on hand | 89.5 | 66.3 | 73.7 | 64.0 | 39.1 | 47.4 | 7.6 | 6.5 | 6.2 | 5.7 |
| Days payables outstanding | 81.2 | 71.2 | 72.6 | 80.6 | 77.4 | 117.8 | 46.3 | 56.6 | 72.0 | 76.5 |
| Cash conversion cycle (days) | 90.2 | 63.9 | 67.2 | 51.7 | 19.8 | 18.9 | 18.6 | -2.0 | -22.7 | -27.8 |
| Receivables turnover | 4.45 | 5.31 | 5.52 | 5.35 | 6.29 | 4.09 | 6.38 | 7.59 | 8.48 | 8.47 |
| Payables turnover | 4.49 | 5.13 | 5.02 | 4.53 | 4.72 | 3.10 | 7.89 | 6.44 | 5.07 | 4.77 |
| Inventory turnover | 4.08 | 5.50 | 4.95 | 5.71 | 9.32 | 7.70 | 47.77 | 55.99 | 58.62 | 64.30 |
| Asset turnover | 0.24 | 0.28 | 0.24 | 0.21 | 0.27 | 0.23 | 0.35 | 0.51 | 0.84 | 0.99 |
| Average receivables | $39.6M | $43.9M | $43.0M | $41.6M | $35.4M | $19.2M | $5.3M | $2.6M | $1.4M | $906,132 |
| Average payables | $20.7M | $26.1M | $26.6M | $27.8M | $26.7M | $13.7M | $2.1M | $1.5M | $1.2M | $959,498 |
| Average inventory | $22.8M | $24.3M | $26.9M | $22.1M | $13.5M | $5.5M | $347,257 | $167,655 | $102,148 | $71,190 |
| Intangibles / total assets | 21.0% | 31.6% | 31.6% | 32.9% | 31.3% | 65.0% | 11.9% | 0.2% | 0.4% | 0.1% |
Computed from CYRX's annual financial statements (latest annual report filed March 5, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
CYRX valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Cryoport traded at 6.1 times earnings. Cryoport earned a return on equity of 17.3% and a return on invested capital of −8.2% in fiscal 2025. It ended the year with $230.7 million of debt and $411.2 million in cash and short-term investments, a net cash position of $180.5 million. It returned $18.0 million to shareholders: $8.0 million in dividends and $10.0 million in share buybacks. The share count rose 252.1% from 14.2M to 50.1M over 9 years.
See the CYRX income statement, the CYRX chart for price history, or the CYRX stock overview for the latest quote and news.
CYRX key metrics FAQ
What is Cryoport's P/E ratio?
Cryoport traded at 6.1 times earnings at the end of fiscal 2025.
What is Cryoport's return on equity?
Cryoport's return on equity (ROE) was 17.3% in fiscal 2025: net income of $78.3 million on average shareholders' equity of $452.3 million.
What is Cryoport's ROIC?
Cryoport's return on invested capital was −8.2% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Cryoport have?
Cryoport had total debt of $230.7 million at the end of fiscal 2025, a debt-to-equity ratio of 0.46 and more cash than debt.
What is Cryoport's dividend yield?
Cryoport paid $8.0 million in dividends in fiscal 2025 ($0.16 per share), a payout ratio of 10.2%.
Does Cryoport buy back its shares?
Yes. Cryoport spent $10.0 million on net share repurchases in fiscal 2025 Shares outstanding changed +2.7% over the year, to 50.1M..
What is Cryoport's free cash flow yield?
Cryoport generated -$28.1 million of free cash flow in fiscal 2025, a free cash flow yield of −5.8% on its market value at year-end ($480.7 million).
What is Cryoport's current ratio?
Cryoport's current ratio was 2.17 at the end of fiscal 2025: current assets were 2.17 times current liabilities.